Washington Russia vaccine prevention HIV Washington Russia

FDA approves first injectable HIV prevention drug, providing option to a daily pill

Reading now: 303

KAZAN, RUSSIA - NOVEMBER 8, 2016: Technicians use microscopes at a laboratory at the Republic of Tatarstan Centre for Prevention and Control of AIDS and Infectious Diseases.

Yegor Aleyev/TASS (Photo by Yegor AleyevTASS via Getty Images) WASHINGTON - The U.S. Food and Drug Administration took a major step in the fight to end the HIV epidemic with the approval of the first injectable HIV prevention drug called Apretude.

Apretude offers an option to prevent HIV that does not involve taking a daily pill. According to the FDA, Apretude is given first to individuals as two injections allocated a month apart and then every two months after.

Read more on fox29.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News